Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for postoperative analgesia after knee or hip arthroplasty
ChiCTR2500096907Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Shanxi Medical University
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of ulinastatin in acute postoperative pain (3 arms), sponsored by First Affiliated Hospital of Shanxi Medical University. Primary endpoints: Morphine consumption and Postoperative adverse reactions. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2500096907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096907.